Average Insider

Where insiders trade, we follow

BridgeBio Pharma, Inc. ($BBIO)
Accession: 0001470831-26-000188
Feb 18, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$28.32
Current$68.5471.0% above low, 29.0% below high
52W High$84.94

Filing Information

Accession Number0001470831-26-000188
Form Type4
Filing DateFeb 18, 2026
Document DateFeb 16, 2026
DocumentView SEC Filing
Transactions
7
Total Shares
160,366
Total Value
$2,330,492.50

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Kumar Neil
Director
Common Stock
โ€”Feb 16, 2026Exercise/Conversion33,544โ€”โ€”262,320Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”Feb 16, 2026Exercise/Conversion19,600โ€”โ€”281,920Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”Feb 16, 2026Exercise/Conversion11,554โ€”โ€”293,474Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”Feb 16, 2026Tax Withholding30,970$75.25$2,330,492.50262,504Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeFeb 16, 2026Exercise/Conversion33,544$0.00$0.00134,176Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeFeb 16, 2026Exercise/Conversion19,600$0.00$0.00156,794Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeFeb 16, 2026Exercise/Conversion11,554$0.00$0.00138,645Directโ€”View Details
Version: v26.3.23